Convalescent plasma therapy for COVID-19 in patients with nasal catheter oxygen therapy.

ABSTRACT:

Background

Numerous studies have demonstrated that convalescent plasma therapy reduces mortality in coronavirus disease 2019 (COVID-19) patients. Current guidelines recommend nasal catheter oxygen therapy for most hypoxic patients during the early stages of the illness. However, limited data are available regarding the efficacy of convalescent plasma therapy in patients already receiving oxygen therapy. Given the widespread use of nasal catheter oxygen therapy in hypoxic COVID-19 patients and the increasing evidence supporting the efficacy of convalescent plasma, this study aimed to evaluate the efficacy and safety of convalescent plasma therapy in COVID-19 patients who were receiving early oxygen therapy.

Methods

A retrospective study was conducted at the First Affiliated H

SUBMITTER: Chen R 

PROVIDER: S-EPMC12268389 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature